Bowel Urgency and Abdominal Pain in Patients With Moderately to Severely Active Ulcerative Colitis in the Etrasimod ELEVATE UC Clinical Program: A Post Hoc Analysis

被引：0
|
作者：
Dubinsky, Marla C. [1 ]
Chaparro, Maria [2 ]
Armuzzi, Alessandro [3 ]
Irving, Peter M. [4 ,6 ]
Allez, Matthieu [5 ]
Panaccione, Remo [6 ]
Goetsch, Martina [7 ]
Bartolome, Lauren [8 ]
Bananis, Eustratios [9 ]
Wu, Joseph [10 ]
Wosik, Karolina [11 ]
Bhattacharjee, Abhishek [12 ]
Smith, Christina C. [9 ]
Sands, Bruce E. [13 ]
机构：
[1] Mt Sinai Kravis Childrens Hosp, New York, NY USA
[2] Univ Autonoma Madrid UAM, Inst Invest Sanitaria Princesa IIS Princesa, Hosp Univ La Princesa, Ctr Invest Biomed Red Hepat & Digest, Madrid, Spain
[3] IRCCS Humanitas Res Hosp, Milan, Italy
[4] Guys & St Thomas Natl Hlth Serv Fdn Trust, London, England
[5] Univ Paris Cite, Hop St Louis, Paris, Ile De France, France
[6] Univ Calgary, Calgary, AB, Canada
[7] Pfizer AG, Zurich, Switzerland
[8] Pfizer Inc, New York, NY USA
[9] Pfizer Inc, Collegeville, PA USA
[10] Pfizer Inc, Cambridge, MA USA
[11] Pfizer Canada, Kirkland, PQ, Canada
[12] Pfizer Healthcare India Pvt Ltd, Chennai, Tamil Nadu, India
[13] Icahn Sch Med Mt Sinai, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1164
引用
收藏
页码：S889 / S890
页数：2
相关论文
共 50 条
  • [31] Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data
    Danese, Silvio
    Tran, Jacinda
    D'Haens, Geert
    Rubin, David T.
    Aoyama, Nobuo
    Zhou, Wen
    Ilo, Dapo
    Yao, Xuan
    Sanchez Gonzalez, Yuri
    Panaccione, Remo
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (11) : 1723 - 1729
  • [32] Efficacy and Safety Profile of Etrasimod Was Not Impacted by Baseline Disease Activity: A Post Hoc Analysis of the ELEVATE UC Program
    Sands, Bruce E.
    Dubinsky, Marla C.
    Kotze, Paulo G.
    Vermeire, Severine
    Panaccione, Remo
    Long, Millie D.
    Woolcott, John C.
    Wu, Joseph
    McDonnell, Aoibhinn
    Goetsch, Martina
    Bananis, Eustratios
    Yarur, Andres J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1044 - S1045
  • [33] Efficacy and Safety Profile of Etrasimod Was Not Impacted by Baseline Disease Activity: A Post Hoc Analysis of the ELEVATE UC Program
    Sands, Bruce E.
    Dubinsky, Marla C.
    Kotze, Paulo G.
    Vermeire, Severine
    Panaccione, Remo
    Long, Millie D.
    Woolcott, John C.
    Wu, Joseph
    McDonnell, Aoibhinn
    Goetsch, Martina
    Bananis, Eustratios
    Yarur, Andres J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10): : S1044 - S1045
  • [34] Etrolizumab Population Pharmacokinetics (Pop PK) and Covariate Analysis in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
    Wei, Xiaohui
    Luca, Diana
    Wang, Yehong
    O'Byrne, Sharon
    Erickson, Rich
    Davis, John
    Tang, Meina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S496 - S496
  • [35] Etrolizumab population pharmacokinetics (Pop PK) and covariate analysis in patients with moderately to severely active ulcerative colitis (UC)
    Wei, X. T.
    Luca, D.
    Wang, Y.
    O'Byrne, S.
    Erickson, R.
    Davis, J. D.
    Tang, M. T.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S46 - S47
  • [36] RELATIONSHIP BETWEEN SYMPTOM RESOLUTION AND CLINICAL RESPONSES AFTER 12 WEEKS OF TREATMENT WITH TULISOKIBART IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A POST HOC ANALYSIS FROM ARTEMIS-UC
    Ma, Christopher
    Boland, Brigid
    Leong, Rupert W.
    Horynski, Marek
    Yen, Mark
    Lu, J. D.
    Luo, Allison
    GASTROENTEROLOGY, 2024, 166 (05) : S807 - S807
  • [37] EFFECT OF RISANKIZUMAB ON EARLY SYMPTOMS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A POST-HOC ANALYSIS OF THE INSPIRE INDUCTION STUDY
    Siegel, Corey A.
    Rubin, David T.
    Panaccione, Remo
    Rieder, Florian
    Takeuchi, Ken
    Hecht, Patrick
    Levine, Phillip
    Gonzalez, Yuri Sanchez
    Zhang, Yafei
    Vladea, Ramona C.
    Biedermann, Luc
    Wu, Kaichun
    GASTROENTEROLOGY, 2024, 166 (05) : S805 - S805
  • [38] SUSTAINED REMISSION WITH VEDOLIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A GEMINI 1 POST HOC ANALYSIS OF WEEK 14 REMITTERS
    Bokemeyer, Bernd
    Stallmach, Andreas
    Axler, Jeffrey L.
    Curtis, Rebecca I.
    Ehehalt, Robert
    Schreiber, Stefan
    Geransar, Parnia
    James, Alexandra
    Kaviya, Arpeat
    Khalid, Javaria M.
    Wolf, Douglas C.
    Feagan, Brian G.
    GASTROENTEROLOGY, 2017, 152 (05) : S604 - S604
  • [39] Sustained remission with vedolizumab in patients with moderately to severely active ulcerative colitis: a GEMINI 1 post hoc analysis of week 14 remitters
    Stallmach, A.
    Bokemeyer, B.
    Axler, J.
    Curtis, R.
    Ehehalt, R.
    Feagan, B.
    Geransar, P.
    James, A.
    Kaviya, A.
    Khalid, J. M.
    Wolf, D.
    Schreiber, S.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S42 - S43
  • [40] Characterization of plasma inflammatory protein abundance in patients with ulcerative colitis treated with etrasimod: an exploratory analysis of the phase 3 ELEVATE UC 52 and ELEVATE UC 12 trials
    Siegmund, B.
    Ryan, R.
    Abreu, M. T.
    Vermeire, S.
    Dotan, I.
    Goetsch, M.
    Crosby, C.
    Woolcott, J.
    Komori, H. K.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 700 - 700
12345